These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 35437240)

  • 1. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
    Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TESC acts as a prognostic factor and promotes epithelial-mesenchymal transition progression in esophageal squamous carcinoma.
    Dong Y; Fan B; Li M; Zhang J; Xie S; Di S; Jia Q; Gong T
    Pathol Res Pract; 2024 Jan; 253():154964. PubMed ID: 38000203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The influence of Ras-associated binding protein 23 knockdown on the migration and invasion of esophageal squamous cell carcinoma cells and its mechanism].
    Ma G; Liang H; Zhang RP; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):108-117. PubMed ID: 38418184
    [No Abstract]   [Full Text] [Related]  

  • 4. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
    Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
    Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
    Chen S; Lin X; He R; Zhang W; Kang M; Xu R
    Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D; He X; Wang W; Hu X; Wang K; Wang M
    Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y; Gao J; Xie X; Nan P; Liu F; Sun Y; Zhao X
    Cancer Med; 2021 May; 10(10):3413-3426. PubMed ID: 33932125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-coding RNA X-Inactive Specific Transcript Promotes Esophageal Squamous Cell Carcinoma Progression via the MicroRNA 34a/Zinc Finger E-box-Binding Homeobox 1 Pathway.
    Guo B; He M; Ma M; Tian Z; Jin J; Tian G
    Dig Dis Sci; 2024 Apr; 69(4):1169-1181. PubMed ID: 38366093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PURα mediates epithelial-mesenchymal transition to promote esophageal squamous cell carcinoma progression by regulating Snail2.
    Gao J; Tian L; Sun Y; Li W; Zhao L; Sun Y; Jing Z; Zhou L; Liu F; Zhao X
    Cancer Lett; 2021 Feb; 498():98-110. PubMed ID: 33144099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway.
    Huang HM; He XH; Huang XY; Wang GY; Xia QX; Du ZP; Zhang YF
    Cell Commun Signal; 2022 Mar; 20(1):35. PubMed ID: 35305679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
    Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-2 mRNA-binding protein 3 promotes cell migration, invasion, and epithelial-mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E-box-binding homeobox 1 mRNA.
    Feng Y; Lin Y; Jiang Z; Wu L; Zhang Y; Wu H; Yuan X
    Mol Carcinog; 2023 Apr; 62(4):503-516. PubMed ID: 36688673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL; Wang WP; Yang YS; Li EM; Xu LY; Chen LQ
    J Cell Mol Med; 2019 Feb; 23(2):1375-1385. PubMed ID: 30565387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant NSG1 Expression Promotes Esophageal Squamous Cell Carcinoma Cell EMT by the Activation of ERK Signaling Pathway.
    Lin X; Tu M; Zhang Y; Zhuang W; Cai L; Zhang L; Yu L; Zhang Z; Huang Y
    Dig Dis Sci; 2023 May; 68(5):1847-1857. PubMed ID: 36396779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A2 combined with TTK accelerates esophageal cancer progression via the Akt/mTOR signaling pathway.
    Liu R; Lu Y; Li J; Yao W; Wu J; Chen X; Huang L; Nan D; Zhang Y; Chen W; Wang Y; Jia Y; Tang J; Liang X; Zhang H
    Cell Death Dis; 2024 Apr; 15(4):291. PubMed ID: 38658569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.